Insiders · Profile

Mayo Stephen

Director at Sarepta Therapeutics · Director at Allogene Therapeutics. Filing since 17 Nov 2022. CIK 0001849061

Company

Date

Role

Action

Amount

Of holding

12 Mar 2026

Director

Sold at will

7,239

$123.21K

80.4%

5 Mar 2024

Director

Sold at will

3,135

$385.48K

32.1%

7 Aug 2023

Director

Sold at will

10,000

$42.86K

28.3%

17 Nov 2022

Director

Sold, plan not stated

858

$94.31K

11.8%

4 decisions on file.